Chris Howerton Profile - Jefferies Analyst
46 Followers
Chris Howerton's Stock Coverage
| MISTMilestone Pharmaceuticals | Jun 20, 2023 | HOLD | Downgraded | $4.00 | 4Ratings | -62.35% | ||
| MCRBSeres Therapeutics | Apr 27, 2023 | BUY | Reiterated | $12.00 | 9Ratings | -54.24% | ||
| HRMYHarmony Biosciences Holdings | Mar 29, 2023 | BUY | Reiterated | $62.00 | 14Ratings | +14.18% | ||
| ACADACADIA Pharmaceuticals | Mar 13, 2023 | SELL | Assigned | $15.00 | 10Ratings | -45.92% | ||
| GPCRStructure Therapeutics, Inc. Sponsored ADR | Feb 28, 2023 | BUY | Initiated | $34.00 | 1Ratings | +69.20% | ||
| CLDXCelldex | Feb 27, 2023 | BUY | Reiterated | $70.00 | 5Ratings | +2.17% | ||
| LQDALiquidia Technologies | Feb 16, 2023 | BUY | Reiterated | $15.00 | 3Ratings | +6.47% | ||
| VRDNViridian Therapeutics | Feb 08, 2023 | BUY | Reiterated | $48.00 | 3Ratings | -20.63% | ||
| VERUVeru | Feb 08, 2023 | SELL | Reiterated | $2.00 | 7Ratings | +19.73% | ||
| URGNUrogen Pharma | Feb 08, 2023 | HOLD | Downgraded | $10.00 | 5Ratings | -48.25% |
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Chris Howerton activity FAQ
What is the performance of Chris Howerton's recommendations?
The percentage of profitable recommendations made by Chris Howerton is 40.64%, and the average return per transaction is 2.10%.
What stocks does Chris Howerton cover?
Chris Howerton mostly covers Milestone Pharmaceuticals, Seres Therapeutics, Harmony Biosciences Holdings stocks.
What was Chris Howerton's most profitable rating?
Chris Howerton’s most profitable rating was a buy on RXDX stock on May 17, 2022. The return on the trade was 501.90%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here
